Last updated on JANUARY 17, 2012
Applies to:Oracle Argus Safety - Version: 188.8.131.52
Information in this document applies to any platform.
Scenario: The case was initially reported to the FDA as a Serious Unlisted case within the Periodic report time frame. Follow-up information was received and the case was downgraded to a Serious Listed case. The downgrade occurred outside of the reporting time frame. The NDA report now list the case twice. Once in the S/L section and again in the S/UL section.
Sign In with your My Oracle Support account
Don't have a My Oracle Support account? Click to get started
Million Knowledge Articles and hundreds of Community platforms